Skip to main content
611 Results
 
Essential Hepatitis C medicine Sofosbuvir and Daclatasvir
Hepatitis C

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

MSF and others have filed an appeal against the European Patent Office’s decision to uphold US pharmaceutical corporation Gilead Science’s patent on the key hepatitis C drug sofosbuvir. Press Release - 5 Dec 2018
 
NAURU - MSF forced to end its Mental Health activities
Nauru

Medical report shows disastrous impact of Australia’s offshore processing policy

Data shows that the mental health suffering among refugees, asylum seekers and Naruans on Nauru is among the worst MSF has ever seen, with Australia's containment policy to blame. Press Release - 2 Dec 2018
 
ENDURING BENTIU
South Sudan

125 women and girls seek emergency assistance in Bentiu after horrific sexual violence

Over the past week, MSF teams have provided emergency medical and psycho-social assistance to 125 women and girls who were raped, beaten and brutalised in Rubkona county, northern South Sudan, in the 10 days between 19 and 29 November. Press Release - 30 Nov 2018
 
Chiradzulu: HIV care for adolescents
HIV/AIDS

Pharmaceutical corporations are failing children with HIV

MSF criticises pharma for dragging feet on developing HIV drugs for children Press Release - 29 Nov 2018
 
Gaza - Lifelong impact of gunshot injuries
Palestine

Gazans’ injuries risk permanently shattering lives

The huge numbers of patients with complex and serious gunshot wounds are overwhelming the healthcare system in Gaza, leaving thousands in danger of infection and disability. Press Release - 29 Nov 2018
 
MSF HIV Testing Clinic's in Conakry
Access to medicines

HIV and TB treatment at risk as countries gradually lose Global Fund support

MSF calls on the Board of the Global Fund to Fight AIDS, TB and Malaria to make urgent changes to prevent drug stock-outs and quality issues with HIV and tuberculosis medicines for countries gradually losing donor support. Press Release - 13 Nov 2018
 
Cécile (cropped Hero image)
Democratic Republic of Congo

Sexual violence committed by armed men in Kasai

Between May 2017 and September 2018, MSF treated 2,600 victims of sexual violence in the town of Kananga in Kasai Central, Democratic Republic of Congo (DRC). Eighty per cent reported having been raped by armed men. Press Release - 1 Nov 2018
 
TB programs in Gulf Province and Port Moresby
Tuberculosis

High prices restrict access to best drug-resistant tuberculosis treatment

MSF calls on US pharma corporation Johnson & Johnson to halve the price of the newer TB drug bedaquiline. Press Release - 23 Oct 2018
 
NAURU - MSF forced to end its Mental Health activities
Nauru

Refugees' lives in danger with MSF forced to end mental healthcare activities

After almost a year of activity in Nauru, MSF has been informed by the government that our mental health activities were “no longer required”. We are extremely concerned for the impact this decision will have on our patients. Press Release - 11 Oct 2018
 
Niger - Magaria Paediatric Unit
Niger

One of the world’s biggest paediatric intensive care units is full

The 200-bed paediatric intensive care unit in Magaria, Niger, is overwhelmed as MSF teams tackle an unprecedented malaria peak in a hospital that covers a region of one million people.

Press Release - 25 Sep 2018
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more